Currently out of the existing stock ratings of Marie Thibault, 137 are a BUY (93.2%), 10 are a HOLD (6.8%).

Marie Thibault

Work Performance Price Targets & Ratings Chart

Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 45.2% that have a potential upside of 30.13% achieved within 121 days.

Marie Thibault’s has documented 290 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ABT, Abbott Laboratories at 23-Jan-2026.

Wall Street Analyst Marie Thibault

Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.

Average potential price target upside

of $34.45 (15.42%) on PODD (INSULET).
of $31.62 (26.23%) on IRTC (IRHYTHM TECHNOLOGIES).
of $26.75 (18.1%) on MASI (MASIMO).

ABT Abbott Laboratories AFIB Acutus Medical ATRC AtriCure BSX Boston Scientific Corp ESTA Establishment Labs Holdings IRT Independence Realty Trust NARI Inari Medical PEAR Pear Therapeutics SENS Senseonics Holdings STIM Neuronetics VAR Varian Medical Systems VRAY ViewRay DXCM DexCom DCTH Delcath Systems PODD Insulet VAPO Vapotherm VERO Venus Concept ARAY Accuray IRTC iRhythm Technologies ICAD icad inc MASI Masimo EMBC Embecta Corp XAIR Beyond Air HAE Haemonetics OM Outset Medical

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score